Your browser doesn't support javascript.
loading
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma.
Feng, Ji; Lu, Pei-Zhi; Zhu, Guang-Zhi; Hooi, Shing Chung; Wu, Yong; Huang, Xiao-Wei; Dai, Hui-Qi; Chen, Pan-Hong; Li, Zhong-Jie; Su, Wen-Jing; Han, Chuang-Ye; Ye, Xin-Ping; Peng, Tao; Zhou, Jing; Lu, Guo-Dong.
Afiliação
  • Feng J; Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, 530021, China.
  • Lu PZ; Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, 530021, China.
  • Zhu GZ; Department of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.
  • Hooi SC; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education (Guangxi Medical University), Nanning, 530021, China.
  • Wu Y; Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Guangxi Medical University, Nanning, 530021, China.
  • Huang XW; Department of Physiology, National University of Singapore, 2 Medical Drive, Singapore, 117593, Singapore.
  • Dai HQ; Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, 530021, China.
  • Chen PH; Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, 530021, China.
  • Li ZJ; Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, 530021, China.
  • Su WJ; Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, 530021, China.
  • Han CY; Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, Nanning, 530021, China.
  • Ye XP; Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, 530021, China.
  • Peng T; Department of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.
  • Zhou J; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education (Guangxi Medical University), Nanning, 530021, China.
  • Lu GD; Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Guangxi Medical University, Nanning, 530021, China.
Acta Pharmacol Sin ; 42(1): 160-170, 2021 Jan.
Article em En | MEDLINE | ID: mdl-32541921
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Coenzima A Ligases / Carcinoma Hepatocelular / Sorafenibe / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans / Male Idioma: En Revista: Acta Pharmacol Sin Assunto da revista: FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Coenzima A Ligases / Carcinoma Hepatocelular / Sorafenibe / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans / Male Idioma: En Revista: Acta Pharmacol Sin Assunto da revista: FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China